These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 22677645)
1. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Blachnio-Zabielska AU; Koutsari C; Tchkonia T; Jensen MD Obesity (Silver Spring); 2012 Dec; 20(12):2341-7. PubMed ID: 22677645 [TBL] [Abstract][Full Text] [Related]
2. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue. Błachnio-Zabielska AU; Pułka M; Baranowski M; Nikołajuk A; Zabielski P; Górska M; Górski J J Cell Physiol; 2012 Feb; 227(2):550-7. PubMed ID: 21437908 [TBL] [Abstract][Full Text] [Related]
3. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. Majumdar I; Mastrandrea LD Endocrine; 2012 Jun; 41(3):442-9. PubMed ID: 22228496 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Ceramide De Novo Synthesis Affects Adipocytokine Secretion and Improves Systemic and Adipose Tissue Insulin Sensitivity. Blachnio-Zabielska AU; Hady HR; Markowski AR; Kurianiuk A; Karwowska A; Górski J; Zabielski P Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545025 [TBL] [Abstract][Full Text] [Related]
5. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome? Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620 [TBL] [Abstract][Full Text] [Related]
6. Diverse Sphingolipid Profiles in Rectal and Colon Cancer. Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046 [TBL] [Abstract][Full Text] [Related]
7. Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6. Hajri T; Tao H; Wattacheril J; Marks-Shulman P; Abumrad NN Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E350-60. PubMed ID: 21062957 [TBL] [Abstract][Full Text] [Related]
8. The Impact of OMEGA-3 Fatty Acids Supplementation on Insulin Resistance and Content of Adipocytokines and Biologically Active Lipids in Adipose Tissue of High-Fat Diet Fed Rats. Chacińska M; Zabielski P; Książek M; Szałaj P; Jarząbek K; Kojta I; Chabowski A; Błachnio-Zabielska AU Nutrients; 2019 Apr; 11(4):. PubMed ID: 31013835 [TBL] [Abstract][Full Text] [Related]
9. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684 [TBL] [Abstract][Full Text] [Related]
10. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats. Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864 [TBL] [Abstract][Full Text] [Related]
11. Body fat mass and the proportion of very large adipocytes in pregnant women are associated with gestational insulin resistance. Svensson H; Wetterling L; Bosaeus M; Odén B; Odén A; Jennische E; Edén S; Holmäng A; Lönn M Int J Obes (Lond); 2016 Apr; 40(4):646-53. PubMed ID: 26563815 [TBL] [Abstract][Full Text] [Related]
12. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Adams JM; Pratipanawatr T; Berria R; Wang E; DeFronzo RA; Sullards MC; Mandarino LJ Diabetes; 2004 Jan; 53(1):25-31. PubMed ID: 14693694 [TBL] [Abstract][Full Text] [Related]
13. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. McGillicuddy FC; Harford KA; Reynolds CM; Oliver E; Claessens M; Mills KH; Roche HM Diabetes; 2011 Jun; 60(6):1688-98. PubMed ID: 21515850 [TBL] [Abstract][Full Text] [Related]
14. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Samad F; Hester KD; Yang G; Hannun YA; Bielawski J Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207 [TBL] [Abstract][Full Text] [Related]
15. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217 [TBL] [Abstract][Full Text] [Related]
16. Metformin treatment affects adipocytokine secretion and lipid composition in adipose tissues of diet-induced insulin-resistant rats. Grycel S; Markowski AR; Hady HR; Zabielski P; Kojta I; Imierska M; Górski J; Blachnio-Zabielska AU Nutrition; 2019; 63-64():126-133. PubMed ID: 30959381 [TBL] [Abstract][Full Text] [Related]
17. Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases. Mondal K; Del Mar NA; Gary AA; Grambergs RC; Yousuf M; Tahia F; Stephenson B; Stephenson DJ; Chalfant CE; Reiner A; Mandal N Lipids Health Dis; 2024 Jun; 23(1):200. PubMed ID: 38937745 [TBL] [Abstract][Full Text] [Related]
18. Ceramide changes in abdominal subcutaneous and visceral adipose tissue among diabetic and nondiabetic patients. Brusatori M; Wood MH; Tucker SC; Maddipati KR; Koya SK; Auner GW; Honn KV; Seyoum B J Diabetes; 2022 Apr; 14(4):271-281. PubMed ID: 35470585 [TBL] [Abstract][Full Text] [Related]
20. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population. Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]